Sutro Biopharma, Inc. (STRO) vs Upstream Bio, Inc. (UPB)
- Sutro Biopharma, Inc. STRO 10.87 −5.15%
- Upstream Bio, Inc. UPB 2.76 −18.10%
Sutro Biopharma, Inc. and Upstream Bio, Inc. are both Biotechnology companies. Sutro Biopharma, Inc. and Upstream Bio, Inc. are of similar size ($190.0M and $184.6M). Upstream Bio, Inc. grew revenue faster over the last twelve months: 16.0% against −56.3%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −4,955.7%) and the higher return on invested capital (0.00% vs −1,100.9%). Across the 14 metrics below, Sutro Biopharma, Inc. leads on 8 and Upstream Bio, Inc. on 6.
Valuation
Profitability
| Metric | STRO | UPB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (319.57%) | (5,382.65%) | 0.00% |
| Net margin | (395.25%) | (4,955.67%) | 0.00% |
| Free cash flow margin | (318.63%) | (4,317.42%) | 0.00% |
| Return on equity | 266.76% | (46.05%) | (56.36%) |
| Return on assets | (79.08%) | (44.61%) | (48.04%) |
| Return on invested capital | 0.00% | (1,100.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack